NCT00147576View on ClinicalTrials.gov

Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects.

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

December 31, 2004

Conditions
Alcoholism
Interventions
DRUG

CP-866,087

Trial Locations (11)

20016

Pfizer Investigational Site, Washington D.C.

29425

Pfizer Investigational Site, Charleston

32901

Pfizer Investigational Site, Melbourne

32935

Pfizer Investigational Site, Melbourne

66219

Pfizer Investigational Site, Lenexa

78229

Pfizer Investigational Site, San Antonio

90703

Pfizer Investigational Site, Cerritos

06504

Pfizer Investigational Site, New Haven

06519

Pfizer Investigational Site, New Haven

02908

Pfizer Investigational Site, Providence

78229-3900

Pfizer Investigational Site, San Antonio

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00147576 - Study To Examine Effect Of CP-866,087 On Consumption And Craving Of Alcohol In Alcohol Dependent Subjects. | Biotech Hunter | Biotech Hunter